Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Advancements in Case Studies

CREALYS®: New Product for Man Infertility in-vivo and in-vitro Results

  • Open or CloseMaggioni C1*, Veit J2, Diaz P2 and Dalmartello M3

    1Humanitas, S. Pio X Obstetrics and Gynecology clinics Via Nava 31 Milano, Italy

    2Department of Biomedical and Pharmaceutical Sciences, USA

    3Department of Clinical Sciences and Community Health, Italy

    *Corresponding author:Cristina Maggioni, Humanitas, S. Pio X Obstetrics and Gynecology clinics Via Nava 31 Milano, Italy

Submission:April 01, 2020; Published: April 14, 2020

DOI: 10.31031/AICS.2020.02.000541

ISSN 2639-0531
Volume2 Issue4

Abstract

Male factor infertility is the most common cause of involuntary childlessness [1,2]. It has been estimated that approximately 15% of reproductive-age couples suffer from infertility, which has become a global concern [3]. Nevertheless, in around 30%-40% of male infertility, no known cause is identified. Oxidative stress is an important factor for development of male infertility. During normal metabolism reactive oxygen species (ROS) produced within the respiratory chain of the mitochondria have the capacity to oxidize and damage cellular constituents such as lipids, proteins and DNA.

Get access to the full text of this article


About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com